Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Risk factors for prostate cancer.
Pienta KJ, Esper PS. Pienta KJ, et al. Among authors: esper ps. Ann Intern Med. 1993 May 15;118(10):793-803. doi: 10.7326/0003-4819-118-10-199305150-00007. Ann Intern Med. 1993. PMID: 8470854 Review.
Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer.
Esper P, Hampton JN, Smith DC, Pienta KJ. Esper P, et al. Oncol Nurs Forum. 1999 Jan-Feb;26(1):107-12. Oncol Nurs Forum. 1999. PMID: 9921573
Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.
Smith DC, Esper P, Strawderman M, Redman B, Pienta KJ. Smith DC, et al. J Clin Oncol. 1999 Jun;17(6):1664-71. doi: 10.1200/JCO.1999.17.6.1664. J Clin Oncol. 1999. PMID: 10561202 Clinical Trial.
A new concept in cancer care: the supportive care program.
Esper P, Hampton JN, Finn J, Smith DC, Regiani S, Pienta KJ. Esper P, et al. Am J Hosp Palliat Care. 1999 Nov-Dec;16(6):713-22. doi: 10.1177/104990919901600608. Am J Hosp Palliat Care. 1999. PMID: 11094908
Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.
Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Esper P, et al. Urology. 1997 Dec;50(6):920-8. doi: 10.1016/S0090-4295(97)00459-7. Urology. 1997. PMID: 9426724
Supportive care, pain management, and quality of life in advanced prostate cancer.
Esper P, Redman BG. Esper P, et al. Urol Clin North Am. 1999 May;26(2):375-89. doi: 10.1016/s0094-0143(05)70077-x. Urol Clin North Am. 1999. PMID: 10361560 Review.
Identifying strategies to optimize care with oral cancer therapy.
Esper P. Esper P. Clin J Oncol Nurs. 2013 Dec;17(6):629-36. doi: 10.1188/13.CJON.629-636. Clin J Oncol Nurs. 2013. PMID: 24305483
Symptom clusters in individuals living with advanced cancer.
Esper P. Esper P. Semin Oncol Nurs. 2010 Aug;26(3):168-74. doi: 10.1016/j.soncn.2010.05.002. Semin Oncol Nurs. 2010. PMID: 20656140 Review.
Melanoma: an under-recognized cancer threat.
Esper P. Esper P. Oncology (Williston Park). 2009 Jul;23(8 Suppl):22. Oncology (Williston Park). 2009. PMID: 19860038 No abstract available.
Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma.
Hellerstedt B, Pienta KJ, Redman BG, Esper P, Dunn R, Fardig J, Olson K, Smith DC. Hellerstedt B, et al. Cancer. 2003 Oct 15;98(8):1603-10. doi: 10.1002/cncr.11686. Cancer. 2003. PMID: 14534875 Clinical Trial.
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback